Devito Vincent, Toscano Fiore, Makaryus Rany
Department of Surgery, NYU Langone Long Island Mineola, NY, USA.
Department of Anesthesiology, NYU Langone Long Island Mineola, NY, USA.
Int J Physiol Pathophysiol Pharmacol. 2024 Jun 15;16(3):77-80. doi: 10.62347/WOOD9895. eCollection 2024.
The everyday clinical practice of anesthesia has been transformed by the new reversal agent Sugammadex. With multiple benefits to this agent, including immediate reversibility of certain neuromuscular blocking agents, a more robust reversal, and the ability to keep a deeper plane of paralysis throughout surgical procedures, this medication has provided anesthesiologists with a new and improved ability to provide high quality care to their patients. The effectiveness of the reversal provided by this agent has also improved the incidence of post-operative complications relating to improper reversal and the need for reintubations. With the new American Society of Anesthesiologists (ASA) guidelines on neuromuscular blockade and its reversal, Sugammadex has been easily and quickly adopted into everyday clinical practice.
新型逆转剂舒更葡糖钠改变了麻醉的日常临床实践。这种药物具有多种益处,包括能立即逆转某些神经肌肉阻滞剂的作用、逆转效果更强,以及在整个手术过程中维持更深程度的麻痹状态,它为麻醉医生提供了新的、更好的能力,以便为患者提供高质量的护理。这种药物提供的逆转效果还降低了与逆转不当及再次插管需求相关的术后并发症发生率。随着美国麻醉医师协会(ASA)关于神经肌肉阻滞及其逆转的新指南出台,舒更葡糖钠已轻松且迅速地被应用于日常临床实践中。